RecruitingNCT04654767
Inflammatory Profiling in Chronic Lung Disease
Sponsor
Ludwig Boltzmann Institute for Lung Vascular Research
Enrollment
60 participants
Start Date
Dec 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to investigate the underlying inflammatory profile in patients with chronic lung disease and determine the association pulmonary hypertension.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patients undergoing lung transplant with COPD or IPF, with associated PH
- Signed informed consent
Exclusion Criteria2
- patients without written informed consent
- Signs of any infection such as pneumonia, pulmonary tuberculosis or infections with pleural effusions.
Interventions
OTHERTissue sampling
Blood collection via venipuncture into citrate- or ethylenediaminetetraacetic (EDTA)-containing vacutainer tubes and into serum tubes. Explant lung tissue obtained from patients that underwent lung transplantation. Non-transplanted donor lungs that had been harvested for transplantation, but not implanted because of size-reduction serve as controls.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04654767
Related Trials
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT0707382036 locations
Development of Novel Physiological CMR Methods in Health and Disease
NCT038540711 location
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT074771971 location
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT017300921 location
Preliminary Human Trials of F230 Tablets
NCT068998151 location